Clinical Trial Efficacy of Autologous Cellular Micrografts in Androgenic Alopecia
February 2023
in “
Research Square (Research Square)
”
TLDR Autologous Cellular Micrografts effectively treat hair loss with significant improvements and no dangerous side effects.
The study evaluated the efficacy of Autologous Cellular Micrografts (ACM) in treating androgenic alopecia (AGA) in 25 patients aged 23-64. Using the Regenera active device, stem cells, progenitor cells, and growth factors were extracted from hair follicles and injected into balding areas. Results showed significant improvements in hair count (+41.56 hair/cm²), hair density (+27.09 hair/cm²), and other hair parameters. Nearly 90% of patients experienced impressive results, indicating that ACM is a promising, effective, and fast treatment for AGA with no dangerous side effects.